Abstract
Single-cell RNA sequencing (scRNA-seq) methods are typically unable to quantify the expression levels of all genes in a cell, creating a need for the computational prediction of missing values ('dropout imputation'). Most existing dropout imputation methods are limited in the sense that they exclusively use the scRNA-seq dataset at hand and do not exploit external gene-gene relationship information. Further, it is unknown if all genes equally benefit from imputation or which imputation method works best for a given gene. Here, we show that a transcriptional regulatory network learned from external, independent gene expression data improves dropout imputation. Using a variety of human scRNA-seq datasets we demonstrate that our network-based approach outperforms published state-of-the-art methods. The network-based approach performs particularly well for lowly expressed genes, including cell-type-specific transcriptional regulators. Further, the cell-to-cell variation of 11.3% to 48.8% of the genes could not be adequately imputed by any of the methods that we tested. In those cases gene expression levels were best predicted by the mean expression across all cells, i.e. assuming no measurable expression variation between cells. These findings suggest that different imputation methods are optimal for different genes. We thus implemented an R-package called ADImpute (available via Bioconductor https://bioconductor.org/packages/release/bioc/html/ADImpute.html) that automatically determines the best imputation method for each gene in a dataset. Our work represents a paradigm shift by demonstrating that there is no single best imputation method. Instead, we propose that imputation should maximally exploit external information and be adapted to gene-specific features, such as expression level and expression variation across cells.
Highlights
Single-cell RNA sequencing has become a routine method, revolutionizing our understanding of biological processes as diverse as tumor evolution, embryonic development, and ageing
Network-based dropout imputation carcinoma data are available in the Single Cell Portal
Human embryonic kidney (HEK) cell data are available in ArrayExpress
Summary
Single-cell RNA sequencing (scRNA-seq) has become a routine method, revolutionizing our understanding of biological processes as diverse as tumor evolution, embryonic development, and ageing. Current technologies still suffer from the problem that large numbers of genes remain undetected in single cells, they are expressed (dropout events). The dropout rate is dependent on the sampling depth, i.e. the number of reads or transcript molecules (determined with unique molecular identifiers, UMIs) quantified in a given cell. Genes with regulatory functions—e.g. transcription factors, kinases, regulatory non-coding RNAs (ncRNAs)—are typically lowly expressed and prone to be missed in scRNAseq experiments. This poses problems for the interpretation of the experiments if one aims at understanding the regulatory processes responsible for the transcriptional makeup of the given cell
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.